Invenomic Capital Management’s Cornerstone Building Brands, Inc. CNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-108,816
Closed -$1.9M 190
2021
Q4
$1.9M Sell
108,816
-28,437
-21% -$442K 0.41% 75
2021
Q3
$2.01M Buy
137,253
+52,140
+61% +$848K 0.65% 52
2021
Q2
$1.55M Sell
85,113
-1,184
-1% -$19.1K 0.37% 55
2021
Q1
$1.21M Buy
86,297
+5,218
+6% +$63.2K 0.27% 69
2020
Q4
$753K Buy
+81,079
New +$720K 0.19% 81
2020
Q1
Sell
-217,395
Closed -$1.85M 180
2019
Q4
$1.85M Buy
+217,395
New +$1.53M 0.74% 56

Other funds holding CNR

Invenomic Capital Management's CNR Position: Q1 2022 in Review

Invenomic Capital Management sold out of Cornerstone Building Brands, Inc. (CNR) in Q1 2022, closing a stake of 108,816 shares — an estimated $1.9M sold.

Invenomic Capital Management first reported a position in CNR in Q4 2019 and held it in 6 quarters. The position peaked at $2.01M in Q3 2021. 185 funds tracked by Wall St. Rank hold CNR as of Q1 2022.

  • Invenomic Capital Management reported no remaining Cornerstone Building Brands, Inc. position as of Q1 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 108,816 Cornerstone Building Brands, Inc. shares in Q1 2022, an estimated $1.9M.
  • Invenomic Capital Management first reported a position in Cornerstone Building Brands, Inc. in Q4 2019 and held it in 6 quarters.
  • Invenomic Capital Management's Cornerstone Building Brands, Inc. position peaked at $2.01M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Cornerstone Building Brands, Inc. as of Q1 2022.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.